SCHEMBL5009253

SCHEMBL5009253

CC(C(=O)c1ccc(Br)cc1)C(C)(C)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
LMNA P02545 4/20 0.42
ALDH1A1 P00352 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
TNNI3 P19429 1/20 0.40
TNNT2 P45379 1/20 0.40
TNNC1 P63316 1/20 0.40
FPR2 P25090 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
GSK3B P49841 2/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21654192 0.85 CES2 (0.46) CES2CES1LMNAALDH1A1CA1
SCHEMBL5006817 0.77 LMNA (0.40) LMNAALDH1A1CA1CA2KMT2A
SCHEMBL727222 0.76 CES2 (0.54) CES2CES1LMNAALDH1A1CA1
SCHEMBL20565073 0.76 CYP1A2 (0.44) LMNAALDH1A1KMT2AMEN1FPR2
SCHEMBL5889317 0.75 CES2 (0.48) CES2CES1LMNAALDH1A1CA1
SCHEMBL23544612 0.74 CES2 (0.52) CES2CES1LMNAALDH1A1CA1
SCHEMBL20703078 0.74 CES2 (0.52) CES2CES1LMNAALDH1A1CA1
SCHEMBL634337 0.74 CES2 (0.52) CES2CES1LMNAALDH1A1CA1
SCHEMBL5011661 0.74 CES2 (0.52) CES2CES1LMNAALDH1A1CA1
SCHEMBL5783383 0.74 CES2 (0.52) CES2CES1LMNAALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423156-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-09 US disclosed